Skip to main content

Fox Health

Panel recommends Lilly continue breast cancer drug study

10 years 1 month ago
Eli Lilly and Co said an interim analysis of a late-stage study testing its breast cancer drug abemaciclib by an independent panel showed the treatment did not meet the effectiveness criteria and recommended that the company continue the trial.
Checked
2 minutes 40 seconds ago
Fox Health
Discover the latest and most breaking health news with Fox News. Read about all things health related and discover the healthy way of living.
Subscribe to Fox Health feed